Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Challenges and solutions for therapeutic TCR-based agents.
Immunol Rev. 2023 Nov;320(1):58-82. doi: 10.1111/imr.13233. Epub 2023 Jul 16.
Immunol Rev. 2023.
PMID: 37455333
Review.
Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment.
Bourne CM, Mun SS, Dao T, Aretz ZEH, Molvi Z, Gejman RS, Daman A, Takata K, Steidl C, Klatt MG, Scheinberg DA.
Bourne CM, et al. Among authors: aretz zeh.
Blood Adv. 2022 Jul 26;6(14):4107-4121. doi: 10.1182/bloodadvances.2021006069.
Blood Adv. 2022.
PMID: 35561310
Free PMC article.
Item in Clipboard
Solving an MHC allele-specific bias in the reported immunopeptidome.
Klatt MG, Mack KN, Bai Y, Aretz ZEH, Nathan LI, Mun SS, Dao T, Scheinberg DA.
Klatt MG, et al. Among authors: aretz zeh.
JCI Insight. 2020 Oct 2;5(19):e141264. doi: 10.1172/jci.insight.141264.
JCI Insight. 2020.
PMID: 32897882
Free PMC article.
Item in Clipboard
A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignancies.
Klatt MG, Dao T, Yang Z, Liu J, Mun SS, Dacek MM, Luo H, Gardner TJ, Bourne C, Peraro L, Aretz ZEH, Korontsvit T, Lau M, Kharas MG, Liu C, Scheinberg DA.
Klatt MG, et al. Among authors: aretz zeh.
Blood. 2022 Aug 25;140(8):861-874. doi: 10.1182/blood.2021012882.
Blood. 2022.
PMID: 35427421
Free PMC article.
Item in Clipboard
Low-dose CDK4/6 inhibitors induce presentation of pathway specific MHC ligands as potential targets for cancer immunotherapy.
Charles A, Bourne CM, Korontsvit T, Aretz ZEH, Mun SS, Dao T, Klatt MG, Scheinberg DA.
Charles A, et al. Among authors: aretz zeh.
Oncoimmunology. 2021 May 24;10(1):1916243. doi: 10.1080/2162402X.2021.1916243.
Oncoimmunology. 2021.
PMID: 34104540
Free PMC article.
Item in Clipboard
An input-controlled model system for identification of MHC bound peptides enabling laboratory comparisons of immunopeptidome experiments.
Klatt MG, Aretz ZEH, Curcio M, Gejman RS, Jones HF, Scheinberg DA.
Klatt MG, et al. Among authors: aretz zeh.
J Proteomics. 2020 Sep 30;228:103921. doi: 10.1016/j.jprot.2020.103921. Epub 2020 Aug 3.
J Proteomics. 2020.
PMID: 32758705
Free PMC article.
Item in Clipboard
Cite
Cite